InvestorsHub Logo
Followers 65
Posts 23922
Boards Moderated 0
Alias Born 11/23/2016

Re: Amatuer17 post# 120719

Tuesday, 09/19/2017 8:15:23 AM

Tuesday, September 19, 2017 8:15:23 AM

Post# of 462441
AXON and NTRP are trying to squeeze efficacy out someone else's drugs that previously failed and have nasty side effects. VTVT, which I also hold in my portfolio is interesting, not least for their diabetes efforts. The market cap of vTv is just about $50M again back in compliance with NASDAQ listing rules and sure to dilute probably several times.

I haven't check, but are also berating those companies on message boards or is it a special treat for AVXL?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News